ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Effects of Diphenyl Diselenide on Carbon Tetrachloride and Diethylnitrosamine-Induced Hepatotoxicity in Wistar Rats

A.O. Adefisan, O. D. Olagoke and*O. A. Adaramoye.



Abstract
Download PDF Post

Chemicals/ drugs-induced hepatotoxicity has become one of the major concerns in medical practice. This study was designed to evaluate the possible protective effects of diphenyl diselenide (DS) against carbon tetrachloride (CCl4) and diethylnitrosamine (DEN)-induced hepatotoxicity in male Wistar rats. Forty male Wistar rats (100-120 g) were assigned into five groups of eight animals. Group 1 served as control, group 2 was given DEN (100 mg/kg) + CCl4 (0.5 ml/kg), group 3 received DEN (100 mg/kg)+ CCl4 (0.5 ml/kg) + DS (5 mg/kg), group 4 received DEN (100 mg/kg)+CCl4 (0.5 ml/kg)+DS (10 mg/kg), and group 5 received DEN (100 mg/kg)+CCl4 (0.5 ml/kg)+Quercetin (QUE; 50 mg/kg). Administration of DEN and CCl4 increased the activities of serum alanine aminotransferase, myeloperoxidase and total bilirubin level relative to controls. There were significant (p

Key words: Diphenyldiselenide, Diethylnitrosamine, carbon tetrachloride, hepatotoxicity, oxidative stress







Bibliomed Article Statistics

30
30
33
30
24
15
11
22
22
25
23
13
R
E
A
D
S

17

28

58

36

22

23

6

21

28

18

21

8
D
O
W
N
L
O
A
D
S
040506070809101112010203
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.